The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy

Acta Radiologica

Volumn 52, Issue 8, 2011, Pages 899-904

  Wong, Christine ^a   Lin, Michael ^a,b   Chicco, Andrew ^b   Benson, Rhonda ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

Cancer; FDG; PET; PET CT; SUV; Thyroid

Indexed keywords

CANCER; FDG; PET-CT; SUV; THYROID;

COMPUTERIZED TOMOGRAPHY; DISEASES; FLUORINE; FOCUSING; GLUCOSE; POLYETHYLENE TEREPHTHALATES; POSITRONS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INCIDENTAL FINDING; MALE; METHODOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; THYROID TUMOR;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; MALE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 83155176450     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.110078     Document Type: Article

References (20)

1. Lin M, Shon IH, Lin P. Positron emission tomography: current status and future challenges. Intern Med J 2010;40:19-29
2. Even-Sapir E, Lerman H, Gutman M, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 2006;33:541-52
3. Boerner AR, Voth E, Theissen P, et al. Glucose metabolism of the thyroid in Graves' disease measured by F-18-Fluoro-Deoxyglucose Positron Emission Tomography. Thyroid 1998;8:765-72
4. Katz SC, Shaha AR. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008;207:259-64
5. Are C, Hsu JF, Schoder H, et al. FDG-PET detected thyroid incidentalomas: Need for further investigation? Ann Surg Oncol 2007;14:239-47
6. Karantanis D, Bogsrud TV, Wiseman GA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007;48:896-901
7. Kim TY, Kim WB, Ryu JS, et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005;115:1074-8
8. Nam SY, Roh JL, Kim JS, et al. Focal uptake of 18F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin Endocrinol (Oxf) 2007;67:135-9
9. Bogsrud TV, Karantanis D, Nathan MA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nuc Med Commun 2007;28:373-81
10. Are C, Hsu JF, Ghossein RA, et al. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol 2007;14:3210-5
11. Yun M, Noh TW, Cho A, et al. Visually discernible [18F]Fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: A potential new risk factor. J Clin Endocrinol Metab 2010;95:3182-8
12. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-Fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88:4100-4
13. Ishigaki S, Shimamoto K, Satake H, et al. Multi-slice CT of thyroid nodules: comparison with ultrasonography. Radiat Med 2004;22:346-53
14. Choi JY, Lee KS, Kim H-J, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006;47:609-15
15. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214
16. Chow SM, Law SCK, Chan JKC, et al. Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98:1-40
17. Hutchings M, Barrington SF. PET/CT for therapy response assessment in lymphoma. J Nucl Med 2009;50:21S-30S
18. Lin M, Wong C, Lin P, et al. The prevalence and clinical significance of 18F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Hematol Oncol 2011;29:67-74
19. Blum R, Prince HM, Hicks RJ, et al. Discordant response to chemotherapy detected by PET scanning: unveiling of a second primary cancer. Am J Clin Oncol 2002;25:368-70
20. De Geus-Oei LF, Pieters GFFM, Bonenkamp JJ, et al. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with indeterminate cytologic results. J Nucl Med 2006;47:770-5